These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3509330)

  • 1. Studies on improvement of pharmaceutical preparations prescribed in hospitals. V. Nifedipine hollow type suppository.
    Namiki N; Yokoyama H; Moriya K; Fukuda M; Takashima T; Tamura H; Yuasa H; Kanaya Y
    Drug Des Deliv; 1986 Nov; 1(2):167-73. PubMed ID: 3509330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of two commercial oral nifedipine products.
    Shaheen O; Zmeili S; al-Qussuois Y; Arafat T; Mouti H
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):337-41. PubMed ID: 1937993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and pharmacokinetic comparison of 2 oral preparations of nifedipine: 10 mg capsules and 20 mg delayed-release tablets].
    Vidal-Gárate J; Castañeda Hernández G; Hoyo Vadillo C; Herrera Abarca JE; Salazar LA; Moreno Ramos A; Fortino Chávez J; Tena I; Hong E
    Arch Inst Cardiol Mex; 1989; 59(1):73-80. PubMed ID: 2486739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The bioavailability of nifedipine in different solid pharmaceutical preparations for oral use].
    Leucuta SE; Vida-Simiti L; Mocan A; Făgărăşan E; Bugnariu S; Baloescu C; Olinic N; Vlaicu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):521-8. PubMed ID: 2577014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in nifedipine concentration-effect relationship between capsule and slow release tablet administration.
    Castañeda-Hernández G; Hoyo-Vadillo C; Herrera JE
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):56-60. PubMed ID: 7711994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the antihypertensive effect of capsule and tablet forms of nifedipine in moderate hypertension].
    Thibonnier M; Sassano P; Corvol P
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():25-8. PubMed ID: 3937501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Inappropriate" physician habits in prescribing oral nifedipine capsules in hospitalized patients.
    Rehman F; Mansoor GA; White WB
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):1035-9. PubMed ID: 8896658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particular features of photolabile substances in tablets.
    Aman W; Thoma K
    Pharmazie; 2003 Sep; 58(9):645-50. PubMed ID: 14531462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sandwiched osmotic tablet core for nifedipine controlled delivery.
    Liu L; Khang G; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(5-6):297-310. PubMed ID: 10822485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of arterial hypertension with nifedipine in patients with chronic renal insufficiency.
    Ambroso GC; Como G; Scalamogna A; Citterio A; Casati S; Ponticelli C
    Clin Nephrol; 1985 Jan; 23(1):41-5. PubMed ID: 3978881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of nifedipine-loaded coated gelatin microcapsule as a long acting oral delivery.
    Li DX; Kim JO; Oh DH; Lee WS; Hong MJ; Kang JY; Choi JS; Woo JS; Yong CS; Choi HG
    Arch Pharm Res; 2009 Jan; 32(1):127-32. PubMed ID: 19183885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy.
    Sawada T; Kondo H; Nakashima H; Sako K; Hayashi M
    Int J Pharm; 2004 Aug; 280(1-2):103-11. PubMed ID: 15265551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
    Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
    Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of nifedipine derived from a new retard tablet formulation.
    Avgerinos A; Gorrod JW
    Eur J Drug Metab Pharmacokinet; 1990; 15(4):273-8. PubMed ID: 2088764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioavailability of new nifedipine preparations in man. 2. Bioequivalence of nifedipine in the form of soft gelatin capsules].
    Dahmen W; Pabst G; Molz KH; Lutz D; Jaeger H
    Arzneimittelforschung; 1985; 35(12):1842-4. PubMed ID: 4096742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on oral sustained-release microspheres of nifedipine].
    Fu CD; Jiang XT; Hu JH; Wu W
    Yao Xue Xue Bao; 1996; 31(9):706-11. PubMed ID: 9863236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of allopurinol oral and rectal dosage forms.
    Chang SL; Kramer WG; Feldman S; Ballentine R; Frankel LS
    Am J Hosp Pharm; 1981 Mar; 38(3):365-8. PubMed ID: 7223751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
    Verdecchia P
    Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences.
    Jann MW; ZumBrunnen TL; Tenjarla SN; Ward ES; Weidler DJ
    Pharmacotherapy; 1998; 18(2):288-94. PubMed ID: 9545148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.